業績

Hiroshi Nomoto, Sho Furusawa, Akinobu Nakamura, Jun Takeuchi, So Nagai, Hiroki Yokoyama, Ichiro Sakuma, Shinji Taneda, Yoshio Kurihara, Shin Aoki, Aika Miya, Hiraku Kameda, Kyu Yong Cho, Tatsuya Atsumi, and Hideaki Miyoshi Effects of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide on glucose metabolism in patients with type 2 diabetes:

protocol for a multi-center, prospective, randomized, open-label, parallel-group comparison study (the SWITCH-SEMA 2 study) BMJ Open, in press

IF: 2.692

ENDO2022（アメリカ内分泌学会）　Outstanding Abstract Award　関崎　知紀先生

Houman G; Kimura H, Kimura H, Makita H, Matsumoto M, Takei N, Shimizu K, Suzuki M, Watanabe T, Kikuchi E, Ohira H, Tsujino I, Sakakibara-Konishi J, Shinagawa N, Shijubo N, Sato H, Shigehara K, Kaga K, Hida Y, Murakami  S, Ebihara Y, Nakamura A, Miyoshi H, Hirano S, Hizawa N, Atsumi T, Huang S, Ito Y, Nishimura M, Konno S.

Effects of obesity on CC16 and their potential role in overweight/obese asthma.

Respir Res, in press.

IF 5.631

Kei Yokozeki, Hiroshi Nomoto, Tatsuya Atsumi.

Diabetic Chorea

J Gen Intern Med., in press

IF: 5.128

Tsuzuki A, Fujioka Y, Yoshida A, Kashiwagi S, Amano M, Hira T, Nakamura A, Miyoshi H, Atsumi T, Ohba Y.

Direct visualization of GLP-1 secretion by fluorescent fusion proteins.

J Diabetes Invest. 2022, in press

IF 4.232

Cho KY, Miyoshi H, Nakamura A, Greenberg AS, Atsumi T.

Lipid droplet protein PLIN1 regulates inflammatory polarity in human macrophages and is involved in atherosclerotic plaque development by promoting stable lipid storage.

J Atheroscler Thromb, in press

IF: 4.928

Nakamura A.

Glucokinase as a therapeutic target based on findings from the analysis of mouse models.

Endocr J, in press

IF: 2.349

公益財団法人 福田記念医療技術振興財団　論文等表彰事業　優秀賞　亀田　玲奈先生

Shibayama Y, Alkhoury C, Nemazanyy I, Henneman N, Cagnard N, Girard M, Atsumi T, Panasyuk G.

Class 3 Phosphatidyl Inositol-3 Kinase Promotes Hepatic Glucocorticoid Receptor Stability and Transcriptional Activity Acta Physiologica, in press

IF: 6.311

Yuki Oe, Hiroshi Nomoto, Akinobu Nakamura, Saki Kuwabara, Yuka Takahashi, Ayano Yasui, Rimi Izumihara, Aika Miya, Hiraku Kameda, Kyu Yong Cho, Tatsuya Atsumi, Hideaki Miyoshi Switching from insulin degludec plus dipeptidyl peptidase-4 inhibitor to insulin degludec/liraglutide improves glycemic variability in patients with type 2 diabetes: a preliminary prospective observation study J Diabetes Res, in press.

IF: 4.011